Sun Pharmaceutical Industries Limited (Sun Pharma) and Taro Pharmaceutical Industries Ltd. (Taro) announced that they have entered into a definitive merger agreement in which Sun Pharma, Taro’s controlling shareholder, has agreed to acquire all of the outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliates for US$43.00 per share in cash…
Galderma and Taro Pharmaceutical Industries Ltd. (Taro) announced they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company (TPC}, from Galderma. The agreement between Galderma and Taro includes Alchemee’s business and assets around the world, including the Proactiv brand. “We are excited to add Proactiv to Taro’s broad portfolio of…
Taro Pharmaceutical Industries Ltd. announced the appointment of Daphne Huang as Vice President, CFO and Chief Accounting Officer, effective today. Huang has over 20 years of senior executive experience in finance; most recently serving as Chief Financial Officer at Humanwell Healthcare USA & Puracap International, having financial oversight of their generic pharmaceutical and OTC portfolios.…
Taro Pharmaceutical Industries Ltd. has announced that it has accepted the resignation of its Chief Financial Officer, Mariano Balaguer, w.e.f January 3, 2020. Balaguer is leaving to accept the position of CFO at another company. The company has initiated a search for a successor as CFO. Uday Baldota, Taro’s CEO, stated, “On behalf of the…